【肺癌】肺癌篩檢「eyonis® LCS」向歐盟提出CE認證申請

 【肺癌】肺癌篩檢「eyonis® LCS」向歐盟提出CE認證申請

 文章出處  

Businesswire 

 

 原文標題  

Median Technologies Files European Application for Class IIb CE Marking of Its AI-Based Software as a Medical Device for Lung Cancer Screening, eyonis® LCS 

 

 Twitter  

https://x.com/aimedadviser/status/1941392118175629692 

 

 文章序號  

8429 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2025 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.